Immuno-potent drugs are largely used in human medicine. The aim of this study was to determine the role of two immuno-modulators (
sodium diethyl-dithiocarbamate, RU 41 740) and two immuno-suppressors (
methylprednisolone,
cyclosporin A) alone or in association with an
unfractionated heparin (
Calciparin), on an experimental
venous thrombosis made by vena cava
ligation in male Wistar rats. Each immuno-potent
drug was administered for six days before the
thrombus induction at the same dosage (10mg/kg b.w.), and the
Calciparin, used as treatment of the
thrombosis, was administered two hours after the
thrombus induction at the dose of 1mg/kg b.w. Immuno-treatment potentiated
thrombus formation: the increase in
thrombus weight was greater with immuno-modulators (43% on average in comparison with placebo) than with immuno-suppressors (20%). In association with
Calciparin the antithrombotic effect was also potentiated and more marked with the immuno-modulators than with immuno-suppressors. An increase in circulating monocytes was observed in all groups whether
Calciparin was present or not. Coagulation tests were not affected by immuno-
therapy. However, immuno-modulators led to an inhibition of platelet aggregation. In conclusion, this trial seems to show a probable effect of immunological cells in
thrombosis and in the antithrombotic effect of
heparin, but the mechanism involved is not yet determined.